Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JAMES HENDRICKS LEWIS

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1396745212
CMS profile
63334
Location
WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$82,686.53

82 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

82 matching records · $82,686.53 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 82 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 82.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Boehringer Ingelheim International GmbH $525.0012/30/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053487 CMS
Otsuka Pharmaceutical Co., Ltd. $869.2512/30/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753029433 CMS
VERTEX PHARMACEUTICALS INCORPORATED $375.0012/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026737096295 CMS
Gilead Sciences, Inc. $400.0012/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820625 CMS
Gilead Sciences, Inc. $400.0012/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820623 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $1,500.0012/10/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798589 CMS
Boehringer Ingelheim International GmbH $525.0012/09/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053485 CMS
Daiichi Sankyo Inc. $1,687.5012/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026964345763 CMS
Gilead Sciences, Inc. $1,780.0012/03/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820621 CMS
VERTEX PHARMACEUTICALS INCORPORATED $437.5011/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026737096287 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $1,100.0011/12/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798585 CMS
Boehringer Ingelheim International GmbH $175.0011/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053463 CMS
Gilead Sciences, Inc. $890.0010/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820619 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $1,500.0010/13/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798581 CMS
Boehringer Ingelheim International GmbH $175.0009/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053497 CMS
VERTEX PHARMACEUTICALS INCORPORATED $500.0009/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026737096293 CMS
Gilead Sciences, Inc. $400.0009/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820617 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $2,000.0009/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798577 CMS
Gilead Sciences, Inc. $1,780.0009/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820615 CMS
Boehringer Ingelheim International GmbH $525.0008/26/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053483 CMS
Gilead Sciences, Inc. $400.0008/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820613 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $900.0008/13/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798573 CMS
Boehringer Ingelheim International GmbH $225.0008/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053477 CMS
Boehringer Ingelheim International GmbH $525.0008/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053479 CMS
Boehringer Ingelheim International GmbH $350.0008/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053481 CMS
Mallinckrodt Hospital Products Inc. $7,875.0008/04/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750986815 CMS
Boehringer Ingelheim International GmbH $112.5007/17/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053475 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $3,500.0007/15/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798569 CMS
Boehringer Ingelheim International GmbH $112.5007/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053465 CMS
Boehringer Ingelheim International GmbH $1,050.0007/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053467 CMS
Boehringer Ingelheim International GmbH $875.0007/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053469 CMS
AbbVie Inc. $23.9606/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721989423 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $1,000.0006/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798565 CMS
Boehringer Ingelheim International GmbH $175.0006/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053501 CMS
VERTEX PHARMACEUTICALS INCORPORATED $562.5005/15/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026737096267 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $3,825.0005/12/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798561 CMS
Gilead Sciences, Inc. $400.0004/29/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820611 CMS
Boehringer Ingelheim International GmbH $175.0004/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053491 CMS
Boehringer Ingelheim International GmbH $525.0004/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053493 CMS
Boehringer Ingelheim International GmbH $1,050.0004/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053495 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $3,200.0004/09/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748798557 CMS
Gilead Sciences, Inc. $3,000.0004/03/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743820609 CMS
Gilead Sciences, Inc. $346.8004/03/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743825217 CMS
Boehringer Ingelheim International GmbH $1,575.0004/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053499 CMS
Boehringer Ingelheim International GmbH $525.0004/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053503 CMS
Boehringer Ingelheim International GmbH $350.0004/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750053505 CMS
Gilead Sciences, Inc. $20.9303/19/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743825213 CMS
Gilead Sciences, Inc. $50.0003/19/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743825215 CMS
Gilead Sciences, Inc. $9.1303/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747983677 CMS
Gilead Sciences, Inc. $28.0003/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747983679 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $215,442.85 152
PY2020 $82,686.53 82
PY2021 $87,277.19 66
PY2022 $145,241.93 82
PY2023 $150,634.46 83
PY2024 $174,626.98 93
PY2025 $146,365.35 83

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
JAMES HENDRICKS LEWIS, NPI 1396745212. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1396745212.
APA 7
IndustryPayments. (2026). JAMES HENDRICKS LEWIS, NPI 1396745212 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1396745212
Bluebook
JAMES HENDRICKS LEWIS, NPI 1396745212, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1396745212.

Source: Centers for Medicare & Medicaid Services, Open Payments.